Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: Amigo Mike who wrote (919)	5/22/1998 6:24:00 AM
From: Pilot	Read Replies (1) \| Respond to of 1476

MIKE - I posted this to Sergio on the "Amigo". SERGIO - ANTX a question? Still in the portfolio? Isn't one of the projects ANTX is working on deal with preventing ear infections in children? If so, this may be important: Investors Business Daily, 5-21-98, Page A4, "Aviron's Nose-Spray Vaccine Prevents Painful Ear Infections". Article cites New England Journal of Medicine study that AVIR's nasal flu vaccine wards off ear infections. I think "Team Amigo" should evaluate the article, maybe someone can scan it or copy it from IBD. Can you put this article in perspective? Seems ANTX's approach is still viable, if indeed they are still researching in this area.